Los Angeles Capital Management LLC Purchases 42,338 Shares of Encompass Health Co. (NYSE:EHC)

Los Angeles Capital Management LLC grew its holdings in Encompass Health Co. (NYSE:EHC - Free Report) by 532.4% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 50,290 shares of the company's stock after purchasing an additional 42,338 shares during the quarter. Los Angeles Capital Management LLC's holdings in Encompass Health were worth $4,860,000 as of its most recent filing with the SEC.

Several other large investors have also recently added to or reduced their stakes in EHC. UMB Bank n.a. increased its position in Encompass Health by 387.7% during the third quarter. UMB Bank n.a. now owns 317 shares of the company's stock worth $31,000 after buying an additional 252 shares during the last quarter. V Square Quantitative Management LLC increased its stake in Encompass Health by 53.0% in the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company's stock valued at $39,000 after acquiring an additional 140 shares during the last quarter. Oakworth Capital Inc. purchased a new stake in shares of Encompass Health in the 2nd quarter worth approximately $40,000. Benjamin F. Edwards & Company Inc. boosted its stake in shares of Encompass Health by 58.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company's stock worth $46,000 after buying an additional 198 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Encompass Health in the 2nd quarter worth approximately $58,000. Institutional investors and hedge funds own 97.25% of the company's stock.

Analyst Upgrades and Downgrades

EHC has been the subject of several recent analyst reports. Stephens restated an "overweight" rating and issued a $105.00 price target on shares of Encompass Health in a research note on Tuesday, August 6th. Barclays lifted their target price on Encompass Health from $109.00 to $116.00 and gave the company an "overweight" rating in a report on Tuesday, October 29th. Royal Bank of Canada boosted their price target on shares of Encompass Health from $105.00 to $110.00 and gave the stock an "outperform" rating in a research report on Wednesday, October 30th. KeyCorp raised their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the stock an "overweight" rating in a report on Tuesday, October 29th. Finally, Truist Financial reissued a "buy" rating and set a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Nine analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Buy" and a consensus target price of $107.11.

Encompass Health Stock Down 0.8 %

Encompass Health stock traded down $0.85 during trading on Tuesday, hitting $102.43. 324,937 shares of the company were exchanged, compared to its average volume of 640,155. The company has a current ratio of 1.04, a quick ratio of 1.35 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $10.32 billion, a P/E ratio of 24.94, a PEG ratio of 1.36 and a beta of 0.88. The business's 50 day moving average is $95.71 and its 200 day moving average is $89.84. Encompass Health Co. has a 52 week low of $63.01 and a 52 week high of $104.55.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.09. The firm had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The firm's quarterly revenue was up 11.9% on a year-over-year basis. During the same period in the previous year, the company earned $0.86 earnings per share. Analysts predict that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health declared that its Board of Directors has authorized a share repurchase plan on Wednesday, July 24th that allows the company to repurchase $500.00 million in outstanding shares. This repurchase authorization allows the company to reacquire up to 5.4% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's board of directors believes its shares are undervalued.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health's payout ratio is currently 16.43%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.